Literature DB >> 23591463

Re: nonsteroidal antiinflammatory drug use, chronic liver disease, and hepatocellular carcinoma.

Paul Singh, Siddharth Singh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23591463     DOI: 10.1093/jnci/djt062

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

Review 1.  Chemopreventive strategies in hepatocellular carcinoma.

Authors:  Siddharth Singh; Preet Paul Singh; Lewis R Roberts; William Sanchez
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-08-13       Impact factor: 46.802

2.  Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.

Authors:  Teng-Yu Lee; Yao-Chun Hsu; Hsiao-Ching Tseng; Shi-Hang Yu; Jaw-Town Lin; Ming-Shiang Wu; Chun-Ying Wu
Journal:  JAMA Intern Med       Date:  2019-05-01       Impact factor: 21.873

Review 3.  Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.

Authors:  Daniel Q Huang; Hashem B El-Serag; Rohit Loomba
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-12-21       Impact factor: 46.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.